Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Propranolol for the Treatment of Kaposi Sarcoma in Children and Adults

NCT05797662 is registered in ClinicalTrials.gov with AIDS Malignancy Consortium as lead sponsor.

NCT NCT05797662
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05797662 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Propranolol for the Treatment of Kaposi Sarcoma in Children and Adults
Lead sponsor
AIDS Malignancy Consortium
Phase
Phase 2
Overall status
Recruiting
Start date
August 31, 2026
Completion date
March 31, 2029
Enrollment
25 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

kaposi sarcoma